Day: March 16, 2023

TORONTO, March 16, 2023 (GLOBE NEWSWIRE) — Middlefield Group (“Middlefield”) announced today that it has concluded the risk rating review of its Exchange Traded Funds (“ETFs”). The risk rating of Middlefield Innovation Dividend ETF (the “Fund”) (TSX:MINN) has been increased from Medium to Medium-to-High, which is reflected in the Prospectus and Fund Facts dated March 16, 2023. The risk rating change is effective immediately and is based on the risk classification methodology mandated by the Canadian Securities Administrators, in accordance with National Instrument 81-102 Investment Funds. Middlefield reviews the risk rating of the ETFs it manages at least on an annual basis, as well as when a fund undergoes a material change. This change is not the result of any changes to the investment objectives, strategies, or management of...

Kansas City, MO, March 16, 2023 (GLOBE NEWSWIRE) — Northern Genesis Acquisition Corp. III (the “Company”) (NYSE: NGC.U; NGC; NGC.WS) today announced that it will redeem all of its outstanding shares of common stock that were included in the units issued in its initial public offering (the “public shares”), effective as of the close of business on March 27, 2023, as the Company will not consummate an initial business combination within the time period required by its Amended and Restated Certificate of Incorporation (the “Charter”). Pursuant to its Charter, if the Company does not complete its initial business combination by March 26, 2023, then the Company will: (i) cease all operations except for the purpose of winding up, (ii) redeem the public shares within ten business days thereafter, at a per-share price, payable in cash,...

New approval based on TADPOLE trial showing overall response rate (ORR) of 47% and median progression-free survival (mPFS) of 20.1 months for Tafinlar + Mekinist compared to 11% ORR and 7.4 months mPFS for standard of care1,2  Approval also received for liquid formulation options for ease of administration across multiple approved indicationsTafinlar + Mekinist is now approved in six indications across multiple BRAF V600E solid tumors, including melanoma, thyroid cancer and lung cancer1,2Basel, March 16, 2023 — Novartis today announced the U.S. Food and Drug Administration (FDA) granted approval for Tafinlar® (dabrafenib) + Mekinist® (trametinib) for the treatment of pediatric patients 1 year of age and older with low-grade glioma (LGG) with a BRAF V600E mutation who require systemic therapy. The FDA also approved liquid formulations...

Golfinho transactions proceeds towards closing With reference to the stock exchange announcement published on 2 March 2023, BW Energy has today been informed that the work related to the Golfinho transactions can be restarted. BW Energy will now continue to prepare for the closing of its acquisition of a 100% operated working interest (WI) in the Golfinho and Camarupim Clusters and 65% WI in the BM-ES-23 block from Petrobras, as well as taking over the FPSO Cidade de Vitoria from Saipem. This preparation work includes progressing relevant approvals from the Brazilian authorities, operational preparedness, field development planning and build-up of the local BW Energy organization. Closing the field transaction and FPSO takeover is subject to fulfilment or waiver of conditions precedent and the restart of the FPSO after upgrades required...

Golden Ocean Group Limited (NASDAQ and OSE: GOGL) (the “Company”) announces that its annual report on Form 20-F for the year ended December 31, 2022 (the “Annual Report”) has been filed with the U.S. Securities and Exchange Commission (the “Commission”). The Annual Report may be accessed through the Company’s website, www.goldenocean.bm, or in the link below. The Annual Report is also available on the website of the Commission, www.sec.gov. Shareholders may also request a hard copy of the Annual Report, which includes the Company’s complete 2022 audited financial statements, by contacting the Investor Relations department.         Golden Ocean Group LimitedHamilton, BermudaMarch 16, 2023 Contact Person: Peder Simonsen: Chief Financial Officer, Golden Ocean Management AS +47 22 01 73 40 This information is subject to the disclosure requirements...

NEW YORK, March 16, 2023 (GLOBE NEWSWIRE) — Logiq, Inc. (OTC:LGIQ), a leading provider of digital consumer acquisition solutions, has today announced the termination of its stock purchase agreement with Ionic Ventures and withdrawal of its S-1 financing facility. Logiq CEO, Brent Suen, stated: “We plan to embark on a decisive path of mergers and acquisitions, given that there is an amazing opportunity to increase our size, presence and revenue profile this year.” About LogiqLogiq Inc. is a U.S.-based provider of e-commerce and digital customer acquisition solutions by simplifying digital advertising. It provides data-driven, end-to-end marketing through its results solution or providing software to access data by activating campaigns across multiple channels. The company’s Digital Marketing business includes a holistic, self-serve...